Login

Switch On Your HIV Smarts.

In people with HIV, over-the-counter heartburn drugs may cause immune activation and inflammation

In people with HIV, over-the-counter heartburn drugs may cause immune activation and inflammation

November 14, 2017, by

A small study linked acid blocking medications like Prilosec to increased inflammation in people living with HIV. What does this study mean for people taking these meds? Read More

PrEP and reaching people of color, trans women, and young people

PrEP and reaching people of color, trans women, and young people

November 7, 2017, by

Not everyone at risk for HIV knows about PrEP, and many people who could benefit from PrEP believe it’s not for them. A panel discussion recently discussed considerations for PrEP providers, advocates, and the media. Read More

Why do some HIV drugs cost so much? Pharma, insurers, advocacy groups and consumers weigh in

Why do some HIV drugs cost so much? Pharma, insurers, advocacy groups and consumers weigh in

November 2, 2017, by

Drug pricing is a complicated issue, with pharmaceutical companies on one side, patient activists on the other, and consumers oftentimes stuck somewhere in the middle. Read More

Why relying on someone else’s PrEP isn’t a good idea

Why relying on someone else’s PrEP isn’t a good idea

October 24, 2017, by

The benefit of PrEP is that it’s a method of HIV prevention completely under your own control. Read More

“Cautious optimism” for three-pronged antibody that blocks simian HIV

“Cautious optimism” for three-pronged antibody that blocks simian HIV

October 17, 2017, by

An engineered “three-pronged” broadly neutralizing antibody successfully blocked simian HIV in a study with monkeys. Broadly neutralizing antibody-based therapies may be used in the future for HIV prevention and/or treatment. Read More